<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Previously described platelet-aggregating antibodies associated with <z:mp ids='MP_0005048'>thrombosis</z:mp> and <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> required <z:chebi fb="5" ids="28304">heparin</z:chebi> for their in vivo and in vitro expression </plain></SENT>
<SENT sid="1" pm="."><plain>We have observed a patient with <z:mp ids='MP_0005048'>thrombosis</z:mp> who became thrombocytopenic during <z:chebi fb="5" ids="28304">heparin</z:chebi> treatment, but who suffered further thrombotic events and continued <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> for 3 months after <z:chebi fb="5" ids="28304">heparin</z:chebi> withdrawal </plain></SENT>
<SENT sid="2" pm="."><plain>The patient's plasma contained a potent platelet aggregating factor reactive with both his own and <z:mpath ids='MPATH_458'>normal</z:mpath> platelets in the absence of <z:chebi fb="5" ids="28304">heparin</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>It also caused [<z:chebi fb="32" ids="36927">14C</z:chebi>]<z:chebi fb="19" ids="28790">serotonin</z:chebi> secretion from labelled platelets from <z:mpath ids='MPATH_458'>normal</z:mpath> donors and patients with either <z:e sem="disease" ids="C0235604" disease_type="Disease or Syndrome" abbrv="">Glanzmann</z:e>'s <z:hpo ids='HP_0004807'>thrombasthenia</z:hpo> or <z:e sem="disease" ids="C0005129" disease_type="Disease or Syndrome" abbrv="">Bernard-Soulier syndrome</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>This factor was an IgG and was neutralized by antibody specific for IgG lambda light chains </plain></SENT>
<SENT sid="5" pm="."><plain>While the patient was thrombocytopenic an IgG paraprotein with lambda light chains was detected by isoelectrofocussing </plain></SENT>
<SENT sid="6" pm="."><plain>After <z:chebi fb="0" ids="50858">corticosteroid</z:chebi> treatment it disappeared and the patient recovered </plain></SENT>
<SENT sid="7" pm="."><plain>The active, but not the recovery serum contained IgG which immunoprecipitated a <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> with characteristics of <z:chebi fb="2" ids="17089">Glycoprotein</z:chebi> IV from platelets labelled with Na[3H]<z:chebi fb="5" ids="30157">BH4</z:chebi>/<z:chebi fb="1" ids="49826">periodate</z:chebi> </plain></SENT>
<SENT sid="8" pm="."><plain>Thus platelet-aggregating IgG antibodies with direct specificity for platelet surface <z:chebi fb="0" ids="17089">glycoproteins</z:chebi> may be associated with <z:mp ids='MP_0005048'>thrombosis</z:mp>/<z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> </plain></SENT>
</text></document>